You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VS-6766

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Recurrent Glioblastoma Trial in Atlanta (Avutometinib, Biospecimen Collection, Defactinib)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Mar 22, 2023

Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)

Recruiting
  • Metastatic Uveal Melanoma
  • Defactinib Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

KRAS Activating Mutation, Metastatic Cancer, Pancreas Cancer Trial in Saint Louis (avutometinib (VS-6766) and defactinib in

Recruiting
  • KRAS Activating Mutation
  • +4 more
  • avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • VS-6766
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

Food Effect Trial in Tempe (VS-6766)

Completed
  • Food Effect
  • VS-6766
  • Tempe, Arizona
    Celerion
May 6, 2022

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

Mesonephric Gynecologic Cancer Trial in United States (VS-6766, Defactinib)

Recruiting
  • Mesonephric Gynecologic Cancer
  • Basking Ridge, New Jersey
  • +6 more
Mar 15, 2023

Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in United States (VS-6766 and sotorasib)

Recruiting
  • Non Small Cell Lung Cancer
  • KRAS Activating Mutation
  • avutometinib (VS-6766) and sotorasib
  • Washington, District of Columbia
  • +6 more
Jan 31, 2023

Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • avutometinib (VS-6766) and adagrasib
  • San Francisco, California
  • +4 more
Dec 21, 2022

Solid Tumours, Multiple Myeloma, Lung Cancer Trial in Sutton, London (VS-6766, Everolimus)

Recruiting
  • Solid Tumours
  • +2 more
  • Sutton, Surrey, United Kingdom
  • +1 more
Apr 25, 2022

Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic Trial in Chicago (VS-6766, Cetuximab, Pill Diary)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • VS-6766
  • +2 more
  • Chicago, Illinois
    University of Chicago Medical Center
Jan 6, 2022

Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Non Small Cell Lung Cancer
  • KRAS Activating Mutation
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Duarte, California
  • +44 more
Dec 22, 2022

NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma Trial in United Kingdom (VS-6766, Defactinib)

Recruiting
  • NSCLC
  • +3 more
  • Manchester, Greater Manchester, United Kingdom
  • +4 more
Mar 18, 2022

Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • Ovarian Cancer
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Scottsdale, Arizona
  • +46 more
Dec 29, 2022

Thyroid Cancer Trial in United States (Avutometinib, Defactinib)

Recruiting
  • Thyroid Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 17, 2023

Pleural Effusions, Chronic, CHF, Shortness of Breath Trial in Los Angeles (tunneled pleural catheter)

Recruiting
  • Pleural Effusions, Chronic
  • +2 more
  • tunneled pleural catheter
  • Los Angeles, California
    UCLA Medical Center
May 18, 2022

Suicide, Suicide Prevention, Suicide and Self-harm Trial in Boise (Caring Contacts)

Not yet recruiting
  • Suicide
  • +2 more
  • Caring Contacts
  • Boise, Idaho
    St. Luke's Health System
Nov 10, 2023

Myopia Trial in Ho Chi Minh City (Myatro, Myatro XL)

Not yet recruiting
  • Myopia
  • Ho Chi Minh City, Vietnam
    University Medical Center HCMC
Apr 5, 2023

Living-Kidney Donors Trial in Cologne (Fasting mimicking diet, Ketogenic diet, Dietary restriction of sulfur containing amino

Not yet recruiting
  • Living-Kidney Donors
  • Fasting mimicking diet
  • +3 more
  • Cologne, Germany
    Department II of Internal Medicine, Center for Molecular Medicin
Feb 2, 2023

Stroke Trial in Irvine (Split belt treadmill, Biofeedback)

Recruiting
  • Stroke
  • Split belt treadmill
  • Biofeedback
  • Irvine, California
    Chapman University
Sep 11, 2023

Chronic Pain, Back Pain, Neck Pain Trial (Tizanidine, MI-Opioid Taper, Placebo)

Not yet recruiting
  • Chronic Pain
  • +3 more
  • (no location specified)
Sep 7, 2023

Healthy, Men, Adults Trial in Brussels (Cycling exercise, Cycling control)

Recruiting
  • Healthy
  • +2 more
  • Cycling exercise
  • Cycling control
  • Brussels, Belgium
    Institute of Neuroscience, UCLouvain
Jul 17, 2023

Lateral Epicondylitis, Rotator Cuff Syndrome Trial in Taipei (combination product, other, drug)

Recruiting
  • Lateral Epicondylitis
  • Rotator Cuff Syndrome
  • lyophilized platelet (30ng) and triamcinolone acetonide 10mg
  • +2 more
  • Taipei, Taiwan
    National Taiwan University Hospital
Dec 12, 2022

Heart Failure NYHA Class III, Heart Failure NYHA Class IV, Chronic Illness Trial (UPHOLDS (Utilizing Palliative Care for Heart

Not yet recruiting
  • Heart Failure NYHA Class III
  • +2 more
  • UPHOLDS (Utilizing Palliative Care for Heart Failure Optimized using Lay Navigators to Decrease Suffering)
  • (no location specified)
May 18, 2023